









Mercado
/
Acciones
/
nasdaq-abeo
/

Abeona Therapeutics Inc

ABEO

4.140USD

-0.050-1.19%

Horarios del mercado （ET）Cotizaciones retrasadas 15 min

212.17MCap. mercado

3.71P/E TTM



Abeona Therapeutics Inc

4.140

-0.050-1.19%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Abeona Therapeutics Inc Compañía

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing cell and gene therapies for life-threatening diseases. The Company’s lead clinical program is for prademagene zamikeracel (pz-cel), its investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company’s fully integrated cell and gene therapy Good Manufacturing Practice (cGMP) manufacturing facility served as the manufacturing site for pz-cel used in its Phase III VIITAL trial and is capable of supporting commercial production of pz-cel upon FDA approval. The Company’s development portfolio also features adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. The Company’s novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases.

Información de Abeona Therapeutics Inc



Símbolo de cotizaciónABEO

Nombre de la empresaAbeona Therapeutics Inc

Fecha de salida a bolsaSep 19, 1980

Director ejecutivoDr. Vishwas (Vish) Seshadri, Ph.D.

Número de empleados136

Tipo de seguridadOrdinary Share

Fin del año fiscalSep 19

Dirección6555 Carnegie Ave, 4th Floor

CiudadCLEVELAND

Bolsa de valoresNASDAQ Capital Market Consolidated

PaísUnited States of America

Código postal44103

Teléfono16468134701

Sitio Webhttps://abeonatherapeutics.com/

Símbolo de cotizaciónABEO

Fecha de salida a bolsaSep 19, 1980

Director ejecutivoDr. Vishwas (Vish) Seshadri, Ph.D.

Ejecutivos de Abeona Therapeutics Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Vishwas (Vish) Seshadri, Ph.D.

President, Chief Executive Officer, Director

1.19M

-0.02%

Mr. Michael Amoroso

Chairman of the Board

180.47K

Dr. Leila Alland, M.D.

Independent Director

154.37K

Mr. Donald A. Wuchterl

Independent Director

145.44K

-3.44%

Ms. Christine Berni Silverstein

Independent Director

120.48K

-9.80%

Mr. Mark J. Alvino

Independent Director

77.34K

-14.48%

Dr. Bernhardt G. Zeiher, M.D.

Independent Director

47.15K

Dr. Eric Crombez, M.D.

Independent Director

Mr. Joseph Vazzano, CPA

Chief Financial Officer

Ms. Faith L. Charles, J.D.

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Vishwas (Vish) Seshadri, Ph.D.

President, Chief Executive Officer, Director

1.19M

-0.02%

Mr. Michael Amoroso

Chairman of the Board

180.47K

Dr. Leila Alland, M.D.

Independent Director

154.37K

Mr. Donald A. Wuchterl

Independent Director

145.44K

-3.44%

Ms. Christine Berni Silverstein

Independent Director

120.48K

-9.80%

Mr. Mark J. Alvino

Independent Director

77.34K

-14.48%

Desglose de ingresos

Sin datos

Sin datos

Por negocio

Por región

Sin datos

Estadísticas de accionistas

Actualizado: vie., 17 de oct

Accionistas

Tipos de accionistas

Accionistas

Proporción

Nantahala Capital Management, LLC

8.90%

Adage Capital Management, L.P.

5.99%

James Russell Revocable Trust

5.31%

BlackRock Institutional Trust Company, N.A.

5.30%

Suvretta Capital Management, LLC

5.22%

Otro

69.28%

Accionistas

Proporción

Nantahala Capital Management, LLC

8.90%

Adage Capital Management, L.P.

5.99%

James Russell Revocable Trust

5.31%

BlackRock Institutional Trust Company, N.A.

5.30%

Suvretta Capital Management, LLC

5.22%

Otro

69.28%

Tipos de accionistas

Accionistas

Proporción

Hedge Fund

30.99%

Investment Advisor

18.32%

Investment Advisor/Hedge Fund

7.85%

Research Firm

5.80%

Individual Investor

5.66%

Venture Capital

5.49%

Corporation

5.31%

Bank and Trust

0.13%

Pension Fund

0.10%

Otro

20.36%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

193

37.80M

73.72%

+611.49K

2025Q2

159

36.70M

71.77%

-2.82M

2025Q1

147

35.53M

69.67%

-3.94M

2024Q4

142

35.48M

81.61%

-1.29M

2024Q3

136

33.53M

77.24%

-4.39M

2024Q2

136

35.81M

86.04%

+12.73M

2024Q1

132

18.43M

63.48%

+1.42M

2023Q4

122

17.76M

63.56%

+2.13M

2023Q3

129

13.60M

55.05%

-1.35M

2023Q2

141

10.67M

49.73%

+4.50K

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Nantahala Capital Management, LLC

4.56M

8.9%

+195.00K

+4.46%

Sep 30, 2025

Adage Capital Management, L.P.

3.07M

5.99%

+381.36K

+14.17%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

2.72M

5.3%

+2.24M

+475.57%

Jun 30, 2025

Suvretta Capital Management, LLC

2.68M

5.22%

-1.01M

-27.39%

Jun 30, 2025

The Vanguard Group, Inc.

2.51M

4.89%

+486.84K

+24.10%

Jun 30, 2025

Western Standard, LLC

2.09M

4.08%

-189.60K

-8.31%

Jun 30, 2025

Vivo Capital, LLC

1.84M

3.59%

Jun 30, 2025

Boone Capital Management LLC

1.25M

2.45%

+1.25M

Jun 30, 2025

Seshadri (Vishwas)

1.19M

2.32%

-44.27K

-3.59%

Sep 30, 2025

ETFs relacionados



Actualizado: jue., 6 de nov

Nombre

Proporción

Simplify Propel Opportunities ETF

4.45%

Vanguard US Momentum Factor ETF

0.04%

iShares Micro-Cap ETF

0.04%

Proshares Ultra Russell 2000

0.01%

ProShares Hedge Replication ETF

0.01%

iShares Russell 2000 Growth ETF

0.01%

ProShares UltraPro Russell2000

0.01%

iShares Russell 2000 ETF

0.01%

Global X Russell 2000 ETF

0.01%

iShares Core S&P Total U.S. Stock Market ETF

Simplify Propel Opportunities ETF

Proporción4.45%

Vanguard US Momentum Factor ETF

Proporción0.04%

iShares Micro-Cap ETF

Proporción0.04%

Proshares Ultra Russell 2000

Proporción0.01%

ProShares Hedge Replication ETF

Proporción0.01%

iShares Russell 2000 Growth ETF

Proporción0.01%

ProShares UltraPro Russell2000

Proporción0.01%

iShares Russell 2000 ETF

Proporción0.01%

Global X Russell 2000 ETF

Proporción0.01%

iShares Core S&P Total U.S. Stock Market ETF

Proporción0%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Jul 01, 2022

Merger

25→1

Jul 01, 2022

Merger

25→1

Jul 01, 2022

Merger

25→1

Jul 01, 2022

Merger

25→1

Fecha

Tipo

Relación

Jul 01, 2022

Merger

25→1

Jul 01, 2022

Merger

25→1

Jul 01, 2022

Merger

25→1

Jul 01, 2022

Merger

25→1

KeyAI

